Occurrence of antibiotics in wastewater treatment facilities in Wisconsin, USA

被引:616
作者
Karthikeyan, KG
Meyer, MT
机构
[1] Univ Wisconsin, Dept Biol Syst Engn, Madison, WI 53706 USA
[2] US Geol Survey, Lawrence, KS 66049 USA
关键词
antibiotics; wastewater; influent; effluent; tetracyclines; sulfonamides; fluoroquinolones; macrolides; trimethoprim;
D O I
10.1016/j.scitotenv.2005.06.030
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Samples from several wastewater treatment facilities in Wisconsin were screened for the presence of 21 antibiotic compounds. These facilities spanned a range of community size served (average daily flow from 0.0212 to 23.6 million gallons/day), secondary treatment processes, geographic locations across the state, and they discharged the treated effluents to both surface and ground waters (for ground water after a soil passage). A total of six antibiotic compounds were detected (1-5 compounds per site), including two sulfonamides (sulfamethazine, sulfamethoxazole), one tetracycline (tetracycline), fluoroquinolone (ciprofloxacin), macrolide (erythromycin-H2O) and trimethoprim. The frequency of detection of antibiotics was in the following order: tetracycline and trimethoprim (80%)> sulfamethoxazole (70%)> erythromycin-H2O (45%)> ciprofloxacin (40%) > sulfamethazine (10%). However, the soluble concentrations were in the parts-per-billion (ppb) range (<= 1.3 mu g/L), and importantly were unaffected by the size of the wastewater treatment facility. The concentrations detected were within an order of magnitude of those reported for similar systems in Europe and Canada: they were within a factor of two in comparison to those reported for Canada but generally lower relative to those measured in wastewater systems in Europe. Only sulfamethoxazole and tetracycline were detected in groundwater monitoring wells adjacent to the treatment systems. Future intensive wastewater monitoring programs in Wisconsin may be limited to the six antibiotic compounds detected in this study. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:196 / 207
页数:12
相关论文
共 26 条
[1]   Occurrence of the pharmaceutical drug clofibric acid and the herbicide mecoprop in various Swiss lakes and in the North Sea [J].
Buser, HR ;
Muller, MD ;
Theobald, N .
ENVIRONMENTAL SCIENCE & TECHNOLOGY, 1998, 32 (01) :188-192
[2]   Occurrence and diversity of tetracycline resistance genes in lagoons and groundwater underlying two swine production facilities [J].
Chee-Sanford, JC ;
Aminov, RI ;
Krapac, IJ ;
Garrigues-Jeanjean, N ;
Mackie, RI .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2001, 67 (04) :1494-1502
[3]   CONCENTRATION AND PERSISTENCE OF OXYTETRACYCLINE IN SEDIMENTS UNDER A MARINE SALMON FARM [J].
COYNE, R ;
HINEY, M ;
OCONNOR, B ;
KERRY, J ;
CAZABON, D ;
SMITH, P .
AQUACULTURE, 1994, 123 (1-2) :31-42
[4]   PENTOBARBITAL FOUND IN-GROUND WATER [J].
ECKEL, WP ;
ROSS, B ;
ISENSEE, RK .
GROUND WATER, 1993, 31 (05) :801-804
[5]   QUINOLONE RESISTANCE IN CAMPYLOBACTER ISOLATED FROM MAN AND POULTRY FOLLOWING THE INTRODUCTION OF FLUOROQUINOLONES IN VETERINARY-MEDICINE [J].
ENDTZ, HP ;
RUIJS, GJ ;
VANKLINGEREN, B ;
JANSEN, WH ;
VANDERREYDEN, T ;
MOUTON, RP .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 27 (02) :199-208
[6]   Ciprofloxacin resistant Campylobacter spp in humans: An epidemiological and laboratory study [J].
Gaunt, PN ;
Piddock, LJV .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 37 (04) :747-757
[7]   Occurrence and fate of antibiotics as trace contaminants in wastewaters, sewage sludges, and surface waters [J].
Giger, W ;
Alder, AC ;
Golet, EM ;
Kohler, HPE ;
McArdell, CS ;
Molnar, E ;
Siegrist, H ;
Suter, MJF .
CHIMIA, 2003, 57 (09) :485-491
[8]   Environmental exposure assessment of fluoroquinolone antibacterial agents from sewage to soil [J].
Golet, EM ;
Xifra, I ;
Siegrist, H ;
Alder, AC ;
Giger, W .
ENVIRONMENTAL SCIENCE & TECHNOLOGY, 2003, 37 (15) :3243-3249
[9]   Occurrence, fate and effects of pharmaceutical substances in the environment - A review [J].
Halling-Sorensen, B ;
Nielsen, SN ;
Lanzky, PF ;
Ingerslev, F ;
Lutzhoft, HCH ;
Jorgensen, SE .
CHEMOSPHERE, 1998, 36 (02) :357-394
[10]  
HARTIG C, 2001, P 2 INT C PHARM END, P84